(Q38629531)

4 September 2017

1 reference

title

The role of estrogen replacement therapy in the prevention of osteoporosis (English)

1 reference

4 September 2017

0 references

Thorneycroft IH

1

1 reference

4 September 2017

language of work or name

English

0 references

publication date

1 May 1989

1 reference

American Journal of Obstetrics and Gynecology

4 September 2017

published in

1 reference

4 September 2017

volume

160

1 reference

4 September 2017

issue

5 Pt 2

1 reference

4 September 2017

page(s)

1306-1310

1 reference

Osteoporosis and the risk of hip fracture

4 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980018-3

Definition of a spine fracture threshold based upon prospective fracture risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980018-3

Bone status and fracture rates in two regions of Yugoslavia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980018-3

Dietary calcium intake and rates of bone loss in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980018-3

Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980018-3

Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980018-3

Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980018-3

POSTMENOPAUSAL OSTEOPOROSIS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980018-3

The menopause: sex steroids and osteoporosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980018-3

Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980018-3

Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980018-3

Post-menopausal oestrogens protect against fractures of hip and distal radius. A case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980018-3

Long-term estrogen replacement therapy prevents bone loss and fractures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980018-3

Incidence of hip fractures in osteoporotic women treated with sodium fluoride

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980018-3

10.1016/S0002-9378(89)80018-3

7 January 2021

Identifiers

DOI

1 reference

4 September 2017

1 reference